Gilad Oren bought APRE
March 12, 2026 · Form 4 insider transaction
Gilad Oren bought 20,175 shares of Aprea Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,175
Price
$0.00
Total value
N/A
InsiderGilad Oren
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 12, 2026
Filing dateMarch 16, 2026
Shares owned after393,895
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares represent restricted stock units and shall vest and be settled in the Issuer's common stock in three (3) equal annual installments beginning on March 12, 2027, until vested in full, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.